Topic: solid oral dosage form

Patheon_Lipid3_listing_250x190

Why are Lipid Formulations Commonly Used to Enhance Bioavailability?

During this webinar, Thermo Fisher Scientific's Kaspar van den Dries and Helena Teles will discuss potential mechanisms of increased absorption with lipid formulations and appropriate screening tools that are used during the development approach of these formulations.
Cambrex-Logo

Pediatric Dosage Form Development – Challenges and Opportunities

The number of pediatric drug approvals has increased 5 fold over the last 20 years, rising from 10-20 approvals per year to 50-60 annually today. Increased awareness around pediatric medicine and FDA support for pediatric clinical research are just some of the factors contributing to this growing market.